Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva
Advanz Pharma's liver treatment Ocaliva lost EU marketing authorization following a court decision. The drug, used for ...
This week, we're highlighting several last-minute changes from federal agencies before the Trump administration takes office.
Novartis is laying off 139 employees in East Hanover, NJ, primarily affecting commercial field sales teams working on Xolair (allergy/asthma) and Tafinlar-Mekinist (cancer) treatments. The cuts, ...
Close to 40 Saab 340 aircraft, including both Saab 340A and Saab 340B passenger aircraft types, have now been converted into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback